Merck, Glaxo to Partner on Renal Cell Cancer Treatment

Merck & Co. said it would start a clinical trial of its cancer-detection immunotherapy and partner GlaxoSmithKline's kinase inhibitor to test the effectiveness of the two drugs in detecting and treating renal cell cancer.



from WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304866904579265960046000936.html?mod=pls_whats_news_us_business_f

via IFTTT